Insulet

Perfil de la empresa

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Descripción disponible en inglés.

Datos societarios

Sector

Salud

Industria

Medical Devices

País

Estados Unidos

Sede

100 Nagog Park, 01720, Acton

Empleados

5.400

Cotización

PODD · NASDAQ

Índices

S&P 500

Divisa

USD

ISIN

US45784P1012

Sitio web

insulet.com